about
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.Rare Case of an Epithelial Cyst in an Intrapancreatic Accessory Spleen Treated by Robot-Assisted Spleen Preserving Distal Pancreatectomy.Use of imaging during symptomatic follow-up after resection of pancreatic ductal adenocarcinoma.Analogous detection of circulating tumor cells using the AccuCyte® -CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer.Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer.Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal Adenocarcinoma.IPMNs with co-occurring invasive cancers: neighbours but not always relatives.Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients.The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysisASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinomaLessons learned from 29 lymphoepithelial cysts of the pancreas: institutional experience and review of the literatureImmunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and PathologyLessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironmentSurvival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical ResectionImplications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal AdenocarcinomaRecurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancerIsolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survivalDefining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal AdenocarcinomaCirculating Tumor DNA as a Clinical Test in Resected Pancreatic CancerPostoperative surveillance of pancreatic cancer patientsPattern of invasion in human pancreatic cancer organoids is associated with loss of SMAD4 and clinical outcome
P50
Q38879932-DE2CBD1D-0924-4F41-AA6D-5988705EABBEQ41819367-76B09D2F-FE70-41BB-8B71-AAB6A6A69C41Q47328451-A017ECA3-228F-4827-BE24-DCBDC3996CBCQ47760107-020BBE29-4774-4BFC-98F1-A12919A689BAQ49793505-811032A8-75B5-4E0F-A662-3AC53F03CA7AQ50045401-D47E816A-F8F2-4FF6-BF3D-E65AA968CA0AQ50074188-1434A3AA-C5FE-4F60-8A41-D68AA88093ECQ50137552-B5C84210-1ACE-4A2A-B953-E5C8E38C8906Q52808681-4F086FE7-ABCC-48F0-98E3-1CDE17C995D8Q54986297-C11A5B21-8990-49F8-B98C-0E07B61FF777Q57163588-AB024A54-721F-4ECF-95D3-F8CB3070F336Q57293247-23730607-DAFE-429F-A7E6-07FA4783F893Q58089491-42A7C682-FCDA-42ED-A2C3-1027C954C206Q61534465-0C7C72FF-5BE6-4DAD-9619-F1AB4DB96B88Q61788101-E387C122-F349-489C-A088-D7B9FA85D09AQ64073922-9458FDAC-A065-44EE-8ED7-A1E1ED7BDD19Q88213642-CACD1AE8-E617-4A11-A883-946B0C8AE6ACQ89285325-1949196F-85B4-460F-B803-2BA9DB7D7D4FQ91520472-20FC875F-9009-4DC2-8C9D-4140A4CB2DD4Q91687707-1ABC0900-AC49-4B45-896C-DD5BAE1DDE2DQ91978227-52120C1D-E0AD-470A-8A4D-743498843ACAQ92380262-61D7DDCA-E5A5-42AA-A172-6F7A6C0E59A4Q92781583-A79E1620-FEE4-4BDB-932B-75EFEA8DD757Q94589796-A3735AAD-6105-4688-872C-18A32892B9D7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Vincent P Groot
@en
Vincent P Groot
@nl
type
label
Vincent P Groot
@en
Vincent P Groot
@nl
prefLabel
Vincent P Groot
@en
Vincent P Groot
@nl
P31
P496
0000-0003-2102-3140